Correlation Between Nyxoah and Nektar Therapeutics

Can any of the company-specific risk be diversified away by investing in both Nyxoah and Nektar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nyxoah and Nektar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Nyxoah and Nektar Therapeutics, you can compare the effects of market volatilities on Nyxoah and Nektar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nyxoah with a short position of Nektar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nyxoah and Nektar Therapeutics.

Diversification Opportunities for Nyxoah and Nektar Therapeutics

0.51

Correlation Coefficient

Nyxoah  Nektar Therapeutics

Very weak diversification

The 3 months correlation between Nyxoah and Nektar is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Nyxoah and Nektar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nektar Therapeutics and Nyxoah is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nyxoah are associated (or correlated) with Nektar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nektar Therapeutics has no effect on the direction of Nyxoah i.e., Nyxoah and Nektar Therapeutics go up and down completely randomly.

Pair Corralation between Nyxoah and Nektar Therapeutics

Given the investment horizon of 90 days Nyxoah is expected to generate 0.83 times more return on investment than Nektar Therapeutics. However, Nyxoah is 1.21 times less risky than Nektar Therapeutics. It trades about 0.41 of its potential returns per unit of risk. Nektar Therapeutics is currently generating about 0.01 per unit of risk. If you would invest  800.00  in Nyxoah on October 23, 2024 and sell it today you would earn a total of  291.00  from holding Nyxoah or generate 36.38% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Nyxoah  vs.  Nektar Therapeutics

Nyxoah

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Nyxoah are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite fairly uncertain basic indicators, Nyxoah demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Nektar Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Nektar Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in February 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Nyxoah and Nektar Therapeutics

The main advantage of trading using opposite Nyxoah and Nektar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nyxoah position performs unexpectedly, Nektar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nektar Therapeutics will offset losses from the drop in Nektar Therapeutics' long position.

The idea behind Nyxoah and Nektar Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.